The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of adjuvant pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153.
 
Greg Andrew Durm
Employment - Cook Biotech
Honoraria - AstraZeneca; Curio Science; Dava Oncology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Mirati Therapeutics (Inst)
 
Muhammad Furqan
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; BeiGene; Jazz Pharmaceuticals; Mirati Therapeutics; Novartis; Omega Therapeutics
Speakers' Bureau - Binaytara Foundation - Education Academy
Research Funding - Abbvie (Inst); Abbvie/Stemcentrx (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); BeiGene (Inst); Biothera (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); Checkmate Pharmaceuticals (Inst); Elicio Therapeutics (Inst); Genentech (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Incyte (Inst); InhibRx (Inst); Jacobus Pharmaceutical Company (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Poseida Therapeutics (Inst); SOPHiA Genetics (Inst)
 
Richard Delmar Hall
Consulting or Advisory Role - Jazz Pharmaceuticals; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Daiichi Sankyo/Lilly (Inst); Genentech; Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Regeneron (Inst)
 
Alberto Chiappori
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Ailleron; Amgen; Daiichi Sankyo/Lilly; G1 Therapeutics; Jazz Pharmaceuticals; Merus; Mirati Therapeutics; Sanofi/Regeneron
Speakers' Bureau - Amgen; Blueprint Medicines; Genentech; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Takeda
 
Patrick C. Ma
Honoraria - AstraZeneca; BeiGene
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Elevation Oncology (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); OncoC4 (Inst); Roche/Genentech (Inst)
 
Lawrence Eric Feldman
Research Funding - E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Roche (Inst)
 
Amit Kulkarni
Stock and Other Ownership Interests - Abbvie; Exact Sciences; Fate Therapeutics; Gilead Sciences; Lilly; Merck; Mirati Therapeutics; Novavax
Consulting or Advisory Role - Exelixis; Genentech
Speakers' Bureau - Regeneron
Research Funding - AstraZeneca
 
Missak Haigentz
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Blueprint Medicines; Coherus Biosciences; Janssen; Jazz Pharmaceuticals; Takeda; Takeda
 
Apar Kishor Ganti
Consulting or Advisory Role - AstraZeneca; Cardinal Health; Eisai; Flagship Biosciences; Genzyme; Jazz Pharmaceuticals; Regeneron
Research Funding - Apexigen (Inst); Chimeric Therapeutics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Nektar (Inst); Novartis (Inst); TopAlliance BioSciences Inc (Inst)
Patents, Royalties, Other Intellectual Property - Oxford University Press
 
Dwight Hall Owen
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Onc.AI (Inst); Palobiofarma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Genentech
 
Rachel E. Sanborn
Honoraria - Curio Science; Illumina; MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; EMD Serono; G1 Therapeutics; GE Healthcare; Gilead Sciences; GlaxoSmithKline; Illumina; Janssen Oncology; Lilly; Macrogenics; Regeneron; Sanofi/Aventis
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Merck
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst); Signatera (Inst)